Bio-View Ltd (TLV: BIOV)
Israel
· Delayed Price · Currency is ILS · Price in ILA
29.90
+0.90 (3.10%)
Jan 20, 2025, 11:27 AM IDT
Bio-View Revenue
Bio-View had revenue of 17.04M ILS in the half year ending June 30, 2024, with 36.39% growth. This brings the company's revenue in the last twelve months to 34.34M, up 0.67% year-over-year. In the year 2023, Bio-View had annual revenue of 34.77M with 19.29% growth.
Revenue (ttm)
34.34M
Revenue Growth
+0.67%
P/S Ratio
1.19
Revenue / Employee
1.04M
Employees
33
Market Cap
38.48M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 34.77M | 5.62M | 19.29% |
Dec 31, 2022 | 29.15M | -1.37M | -4.48% |
Dec 31, 2021 | 30.51M | 4.55M | 17.54% |
Dec 31, 2020 | 25.96M | -9.83M | -27.47% |
Dec 31, 2019 | 35.79M | 10.51M | 41.57% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 62.35B |
Danel (Adir Yeoshua) | 2.71B |
Kamada | 588.75M |
Bait Bakfar | 102.08M |
Novolog (Pharm-Up 1966) | 1.73B |
Ilex Medical | 982.96M |
BrainsWay | 143.60M |
SofWave Medical | 210.53M |